Abstract:
Introduction. Vestibular migraine (VM) is the most common cause of recurrent spontaneous vertigo, affecting 1-3% of the population and 10-30% of patients seeking care for dizziness. Despite its prevalence, it is underdiagnosed: 80% of patients consult for vertigo, but fewer than 20% receive the correct diagnosis. VM presents with recurrent moderate to severe vertigo lasting minutes to hours, often accompanied by nausea, vomiting, nystagmus, photophobia, phonophobia and migraine-like headache, making its recognition challenging. Aim of study. To summarize current concepts regarding the mechanisms responsible for the development of vestibular vertigo in VM. Methods and materials. A review of clinical and experimental studies from the last 10 years was conducted using PubMed, ScienceDirect, Scopus, and other sources, focusing on proposed pathophysiological mechanisms. Results. Vertigo in VM is thought to result from abnormal processing of vestibular signals within central and peripheral structures of the vestibular system. One important mechanism involves interaction between the trigeminovascular system and vestibular pathways. Activation of trigeminal afferents leads to the release of neuropeptides such as calcitonin gene-related peptide (CGRP), substance P and neurokinin A. These mediators can influence vestibular nuclei and increase the excitability of vestibular neurons, which may trigger vertigo. Cortical spreading depression is another mechanism implicated in vestibular symptoms. This wave of neuronal depolarization spreads across the cerebral cortex and alters neuronal activity. When it involves cortical regions responsible for spatial orientation and vestibular integration, disturbances in the perception of motion and body position may occur. Dysfunction of thalamocortical networks also contributes to vestibular manifestations. The thalamus integrates vestibular signals and transmits them to cortical vestibular areas. Altered thalamic modulation may increase sensitivity to motion stimuli and lower the threshold for perception of vestibular signals, explaining the motion intolerance commonly observed in VM patients. Neuroimaging demonstrates altered activity in temporoparietal cortical areas, supporting the vestibulo-thalamo-cortical pathway's role. Peripheral mechanisms, including calcium channel dysfunction and transient labyrinthine artery vasospasm, may impair inner ear function, contributing to episodic vertigo and nystagmus. Conclusions. Vertigo in VM results from complex interactions between trigeminovascular activation, cortical spreading depression, altered thalamocortical processing, and possible peripheral vestibular dysfunction. A better understanding of these mechanisms may improve diagnostic accuracy, guide targeted therapeutic strategies, and help prevent misdiagnosis of vestibular disorders.